Literature DB >> 8246279

K-ras gene mutation as a pathogenetic and diagnostic marker in human cancer.

E R Fearon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8246279     DOI： 10.1093/jnci/85.24.1978

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

Review 1.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

2.  Clinical significance of K-ras oncogene activation in ampullary neoplasms.

Authors:  C H Chung; R E Wilentz; M M Polak; T B Ramsoekh; L A Noorduyn; D J Gouma; K Huibregtse; G J Offerhaus; R J Slebos
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

3.  Alteration of p53 and p21 during hepatocarcinogenesis in tree shrews.

Authors:  Jian-Jia Su; Ke-Chen Ban; Yuan Li; Liu-Liang Qin; Hui-Yun Wang; Chun Yang; Chao Ou; Xiao-Xian Duan; Young-Lk Lee; Rui-Qi Yang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

4.  Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.

Authors:  Ronald van Eijk; Marjo van Puijenbroek; Amiet R Chhatta; Nisha Gupta; Rolf H A M Vossen; Esther H Lips; Anne-Marie Cleton-Jansen; Hans Morreau; Tom van Wezel
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

5.  Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.

Authors:  W Giaretti; R Monaco; N Pujic; A Rapallo; S Nigro; E Geido
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 6.  Molecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literature.

Authors:  B Klump; O Nehls; T Okech; C-J Hsieh; V Gaco; F S Gittinger; M Sarbia; F Borchard; A Greschniok; H H Gruenagel; R Porschen; M Gregor
Journal:  Int J Colorectal Dis       Date:  2003-06-21       Impact factor: 2.571

Review 7.  Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Authors:  Z Sheng Guo; Stephen H Thorne; David L Bartlett
Journal:  Biochim Biophys Acta       Date:  2008-02-15

Review 8.  Novel gene therapy approaches to pancreatic cancer.

Authors:  Matthew H Katz; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2003

9.  A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.

Authors:  T Ohnishi; N Tomita; T Monden; M Ohue; I Yana; K Takami; H Yamamoto; T Yagyu; N Kikkawa; T Shimano; M Monden
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.

Authors:  J S Carew; C M Espitia; W Zhao; K R Kelly; M Coffey; J W Freeman; S T Nawrocki
Journal:  Cell Death Dis       Date:  2013-07-18       Impact factor: 8.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.